Back
Harvard Bioscience Quote, Financials, Valuation and Earnings
Sell
37
HBIO
Harvard Bioscience
Last Price:
2.82
Seasonality Move:
1.99%
7 Day Trial
ALL ACCESS PASS
$
7
Harvard Bioscience Price Quote
$2.82
-0.05 (-1.74%)
(Updated: June 21, 2024 at 4:35 PM ET)
Harvard Bioscience Key Stats
Sell
37
Harvard Bioscience (HBIO)
is a Sell
Day range:
$2.81 - $2.95
52-week range:
$2.75 - $6.20
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.15
P/B ratio:
1.81%
Volume:
92.8K
Avg. volume:
139.5K
1-year change:
-51.6%
Market cap:
$124.6M
Revenue:
$112.3M
EPS:
$-0.2
How Much Does Harvard Bioscience Make?
-
How Much Are Harvard Bioscience's Sales Annually?
HBIO Revenues are $112.3M -
How Much Profit Does Harvard Bioscience's Make A Year?
HBIO net income is -$3.4M
Is Harvard Bioscience Growing As A Company?
-
What Is Harvard Bioscience's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.18% -
What Is Harvard Bioscience's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Harvard Bioscience Stock Price Performance
-
Did Harvard Bioscience Stock Go Up Last Month?
Harvard Bioscience share price went down by -12.23% last month -
Did HBIO's Share Price Rise Over The Last Year?
HBIO share price fell by -51.6% over the past 1 year
What Is Harvard Bioscience 52-Week High & Low?
-
What Is Harvard Bioscience’s 52-Week High Share Price?
Harvard Bioscience has traded as high as $6.20 over the past 52 weeks -
What Is Harvard Bioscience’s 52-Week Low Share Price?
Harvard Bioscience has traded as low as $2.75 over the past 52 weeks
Harvard Bioscience Price To Free Cash Flow
-
Is Harvard Bioscience Stock Overvalued?
Harvard Bioscience is trading at a price to free cash flow ratio of 11.35 -
Is Harvard Bioscience Stock Undervalued?
Harvard Bioscience EV to Free Cash Flow ratio is 14.43 -
What Is Harvard Bioscience’s Price Earnings Growth Ratio?
HBIO PEG ratio is -0.05 -
Is Harvard Bioscience Trading At A Premium To Earnings?
Harvard Bioscience EV to EBIT ratio is 0.00
Is It Risky To Buy Harvard Bioscience?
-
How Much Debt Does Harvard Bioscience Have?
Total long term debt quarterly is $35.6M -
How Much Cash Does Harvard Bioscience Have?
Cash and short term investments quarterly total is $4.3M -
What Is Harvard Bioscience’s Book Value Per Share?
Book value per share is 1.58
Is Harvard Bioscience Cash Flow Positive?
-
What Is HBIO Cash Flow From Operations?
Cash flow from operations (TTM) is $13.6M -
What Is Harvard Bioscience’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$10.3M -
What Is Harvard Bioscience’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$2.3M
Harvard Bioscience Return On Invested Capital
-
Is Management Doing A Good Job?
HBIO return on invested capital is -7.76% -
What Is Harvard Bioscience Return On Assets?
ROA measures how assets are converting to revenues and is -6.25% -
What Is HBIO Return On Equity?
ROE is a measure of profitability and is -11.93%
Harvard Bioscience Earnings Date & Stock Price
-
What Is Harvard Bioscience's Stock Price Today?
A single share of HBIO can be purchased today for 2.87 -
What Is Harvard Bioscience’s Stock Symbol?
Harvard Bioscience trades on the nasdaq under the ticker symbol: HBIO -
When Is Harvard Bioscience’s Next Earnings Date?
The next quarterly earnings date for Harvard Bioscience is scheduled on August 8, 2024 -
When Is HBIO's next ex-dividend date?
Harvard Bioscience's next ex-dividend date is June 21, 2024 -
How To Buy Harvard Bioscience Stock?
You can buy Harvard Bioscience shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Harvard Bioscience Competitors
-
Who Are Harvard Bioscience's Competitors?
Below is a list of companies who compete with Harvard Bioscience or are related in some way:
Harvard Bioscience Dividend Yield
Data Unavailable
Harvard Bioscience Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -20% |
| Revenue: | -18.23% | -4.99% |
Analyst Recommendations
| Buy Recommendations: | 2 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 7.00 |
| Upside from Last Price: | 143.9% |